CC BY-NC-ND 4.0 · Indian J Plast Surg 2017; 50(03): 288-294
DOI: 10.4103/ijps.IJPS_179_15
Original Article
Association of Plastic Surgeons of India

The conundrum of deep vein thrombosis prophylaxis in burns in India and review of literature

S. S. Shirol
Department of Plastic Surgery, KIMS, Hubli, Karnataka
,
Srinivas Kodaganur
Department of Plastic Surgery, KIMS, Hubli, Karnataka
,
M. Raghavendra Rao
1   Department of Rehabilitative Medicine, HCG, Bengaluru, Karnataka
,
Vinaykumar Tiwari
2   Department of Plastic Surgery, RML Hospital, New Delhi, India
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
10. Juli 2019 (online)

ABSTRACT

Objective: The aim is to assess the practice of deep vein thrombosis (DVT) prophylaxis among the plastic surgeons attending National Academy of Burns India Conference 2012 (NABICON 2012). Background: DVT prophylaxis in burns is a controversial issue as there is no consensus among the community of burn surgeons about the prevalence of DVT, the incidence of pulmonary embolism, the indications for DVT prophylaxis, dosage and duration of low molecular weight heparins (LMWH) and the complications related to DVT and LMWH. Methodology: A survey was conducted among plastic surgeons attending the NABICON 2012 held at New Delhi, by circulating a questionnaire. The respondents were divided into two groups based on whether burns constituted more than or less than 50% of their practice. The data thus collected were tabulated and analysed. Results: Almost 70% of all the respondents practice some form of DVT prophylaxis. There was significantly higher incidence of complications related to the use of LMWH among the surgeons whose practice of burns was >50%. There was no significant difference between the two groups in relation to the incidence and complication of DVT or recommendation of DVT prophylaxis. Conclusion: Majority of plastic surgeons practice DVT prophylaxis routinely and consider multiple criteria such as percentage of burns, age, lower limb involvement, the degree of burns and associated co-morbidities for starting the LMWH.

 
  • REFERENCES

  • 1 King DR, Namias N, Andrews DM. Coagulation abnormalities following thermal injury. Blood Coagul Fibrinolysis 2010; 21: 666-9
  • 2 Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR. et al. Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133: 381S-453S
  • 3 Wahl WL, Brandt MM, Ahrns KS, Zajkowski PJ, Proctor MC, Wakefield TW. et al. Venous thrombosis incidence in burn patients: Preliminary results of a prospective study. J Burn Care Rehabil 2002; 23: 97-102
  • 4 Pannucci CJ, Osborne NH, Wahl WL. Venous thromboembolism in thermally injured patients: Analysis of the national burn repository. J Burn Care Res 2011; 32: 6-12
  • 5 Ferguson RE, Critchfield A, Leclaire A, Ajkay N, Vasconez HC. Current practice of thromboprophylaxis in the burn population: A survey study of 84 US burn centers. Burns 2005; 31: 964-6
  • 6 Fecher AM, O'Mara MS, Goldfarb IW, Slater H, Garvin R, Birdas TJ. et al. Analysis of deep vein thrombosis in burn patients. Burns 2004; 30: 591-3
  • 7 Wahl WL, Brandt MM. Potential risk factors for deep venous thrombosis in burn patients. J Burn Care Rehabil 2001; 22: 128-31
  • 8 Townsend Jr. C, Beauchamp DR, Evers BM. Sabiston Textbook of Surgery. 6th ed.. New Delhi: Elsevier; 2011
  • 9 Lin H, Faraklas I, Saffle J, Cochran A. Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients. J Trauma 2011; 71: 1557-61
  • 10 Sebastian R, Ghanem O, DiRoma F, Milner SM, Price LA. Pulmonary embolism in burns, is there an evidence based prophylactic recommendation?. Case report and review of literature. Burns 2015; 41: e4-7
  • 11 Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson Jr FA. et al. Prevention of venous thromboembolism. Chest 2001; 119: 132S-75S
  • 12 Cayley Jr WE. Preventing deep vein thrombosis in hospital inpatients. BMJ 2007; 335: 147-51
  • 13 Bloemsma GC, Dokter J, Boxma H, Oen IM. Mortality and causes of death in a burn centre. Burns 2008; 34: 1103-7
  • 14 Brunton L, Chabner B, Knollman B. Goodman & Gillman's Pharmacological Basis of Therapeutics. 12th ed.. New York: McGraw-Hill; 2011
  • 15 Lumpkin MM. FDA public health advisory. Anesthesiology 1998; 88: 27A-8A
  • 16 Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506-11
  • 17 Harrington DT, Mozingo DW, Cancio L, Bird P, Jordan B, Goodwin CW. et al. Thermally injured patients are at significant risk for thromboembolic complications. J Trauma 2001; 50: 495-9
  • 18 Lippi G, Ippolito L, Cervellin G. Disseminated intravascular coagulation in burn injury. Semin Thromb Hemost 2010; 36: 429-36
  • 19 Drugs@FDA: FDA Approved Drug Products. 2015 Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda [Last accessed on 2015 Sep 05].
  • 20 Caprini JA, Arcelus J, Sehgal LR, Cohen EB, Reyna JJ. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States. Int Angiol 2002; 21: 78-85
  • 21 Proceedings of the American Burn Association 45th Annual Meeting. 1st ed.. Boston: Burn Science Publisher; 2013
  • 22 Proceedings of the American Burn Association 46th Annual Meeting. 1st ed.. Boston: Burn Science Publisher; 2014
  • 23 Proceedings of the American Burn Association 47th Annual Meeting. 1st ed.. Chicago: Burn Science Publisher; 2015
  • 24 Convenus.com. 2015 Available from: http://www.convenus.com/bba/ [Last accessed on 2015 Sep 05].